查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605808

醫藥品·醫療設備組合產品市場，規模，佔有率，趨勢，產業分析報告:各產品類型，各用途，各終端用戶，各地區 - 市場預測，2025年～2034年

Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type, Application, End user, and Region- Market Forecast, 2025 - 2034
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2034年，全球組合藥物和醫療器材市場預計將達到3,435.9億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

世界各地不斷增長的老年人口正在推動全球藥物/醫療器材組合產品市場的發展。老年人通常患有多種慢性疾病，例如糖尿病、高血壓和關節炎。將藥物輸送與監測和其他支援功能結合起來的藥物-器械組合產品的需求不斷增長，因為它們在滿足這些複雜的健康要求方面特別有利。因此，老年人口的增加正在擴大市場。

根據聯合國發布的報告，全球65歲及以上人口數量預計將增加一倍以上，從2021年的7.61億增至2050年的16億。

糖尿病盛行率的上升正在為全球組合藥物和醫療器材市場注入活力。管理糖尿病需要持續的藥物治療和監測。胰島素幫浦和連續血糖監測儀 (CGM) 等組合藥物和醫療設備產品透過將藥物輸送和監測整合到一台設備中，簡化了糖尿病管理並提高了患者的便利性，從而推動了需求。

藥物輸送活動投資的增加正在推動全球藥物-醫療器材組合產品市場的發展。這個市場上的公司可以開發滿足特定醫療需求的產品，並且透過增加投資，可以超越當前的解決方案。因此，對更先進和現代化的藥物輸送設備的需求日益增長。

藥品/醫療器材組合產品市場報告亮點

透皮貼片細分市場因其非侵入性性質而在 2024 年佔據市場佔有率，這符合對微創和患者友好型給藥解決方案不斷增長的需求。

藥物洗脫支架段預計在研究期間將出現最高增長，因為它可以透過釋放預防動脈再狹窄的藥物來有效治療冠狀動脈疾病。

由於迫切需要先進技術來管理冠狀動脈疾病和心臟衰竭，心血管疾病領域在 2024 年佔據最大的市場佔有率。

由於先進的醫療基礎設施、高水準的研發活動以及支持技術創新和市場進入的強有力的監管框架，北美在 2024 年佔據了市場主導地位。此外，大量主要製藥和醫療器材公司的存在也有助於該領域的主導地位。

亞太地區，被預測把醫療保健部門的擴大，醫療技術的投資的增加，患者數的增加做為背景，記錄在調查期間中最快的成長。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球醫藥品·醫療設備組合產品市場洞察

  • 市場概述
  • 醫藥品·醫療設備組合產品市場力學
    • 促進因素和機會
      • 糖尿病盛行率的上升推動了市場的發展
      • 全球老年人口增加促使市場擴張
    • 阻礙因素與課題
      • 複雜的監管環境抑制藥品/醫療器材組合產品市場的成長
  • PESTEL分析
  • 醫藥品·醫療設備組合產品市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球醫藥品·醫療設備組合產品市場:各類型

  • 主要調查結果
  • 簡介
  • 藥物釋放型血管支架
  • 輸液幫浦
  • 吸入器
  • 整形外科用複合產品
  • 創傷護理複合產品
  • 光線動態療法設備
  • 經皮吸收貼片
  • 抗菌導管
  • 其他

第6章 全球醫藥品·醫療設備組合產品市場:各用途

  • 主要調查結果
  • 簡介
  • 心血管疾病
  • 糖尿病
  • 呼吸系統的問題
  • 癌症治療
  • 其他

第7章 全球醫藥品·醫療設備組合產品市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 醫院
  • 門診病人手術中心
  • 其他

第8章 全球醫藥品·醫療設備組合產品市場:各地區

  • 主要調查結果
  • 簡介
    • 醫藥品·醫療設備組合產品市場評估:各地區，2020年～2034年
  • 北美
    • 北美:各類型，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 北美:各終端用戶，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型，2020-2034
    • 歐洲:各用途，2020年～2034年
    • 歐洲:各終端用戶，2020年～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類型，2020年～2034年
    • 亞太地區:各用途，2020年～2034年
    • 亞太地區:各終端用戶，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類型，2020年～2034年
    • 中東·非洲:各用途，2020年～2034年
    • 中東·非洲:各終端用戶，2020年～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類型，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 南美:各終端用戶，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Medtronic
  • Novartis AG
  • Sensely, Inc.
  • Stryker
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Viatris Inc.
  • Hovione
Product Code: PM5167

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.

Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.

Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.

North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.

Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.

The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

  • Drug Eluting Stents
  • Infusion Pumps
  • Inhalers
  • Orthopedic Combination Products
  • Wound Care Combination Products
  • Photodynamic Therapy Devices
  • Transdermal Patches
  • Antimicrobial Catheters
  • Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

  • Cardiovascular Disorder
  • Diabetes
  • Respiratory Problems
  • Cancer Treatment
  • Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Drug Device Combination Products Market Insights

  • 4.1. Drug Device Combination Products Market - Market Snapshot
  • 4.2. Drug Device Combination Products Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of diabetes is driving the market.
      • 4.2.1.2. Growing geriatric population worldwide propels the market.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex regulatory environment is hindering the drug device combination products market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Drug Device Combination Products Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Drug Device Combination Products Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Drug Eluting Stents
    • 5.3.1. Global Drug Device Combination Products Market, by Drug Eluting Stents, by Region, 2020-2034 (USD Billion)
  • 5.4. Infusion Pumps
    • 5.4.1. Global Drug Device Combination Products Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
  • 5.5. Inhalers
    • 5.5.1. Global Drug Device Combination Products Market, by Inhalers, by Region, 2020-2034 (USD Billion)
  • 5.6. Orthopedic Combination Products
    • 5.6.1. Global Drug Device Combination Products Market, by Orthopedic Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.7. Wound Care Combination Products
    • 5.7.1. Global Drug Device Combination Products Market, by Wound Care Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.8. Photodynamic Therapy Device
    • 5.8.1. Global Drug Device Combination Products Market, by Photodynamic Therapy Device, by Region, 2020-2034 (USD Billion)
  • 5.9. Transdermal Patches
    • 5.9.1. Global Drug Device Combination Products Market, by Transdermal Patches, by Region, 2020-2034 (USD Billion)
  • 5.10. Antimicrobial Catheters
    • 5.10.1. Global Drug Device Combination Products Market, by Antimicrobial Catheters, by Region, 2020-2034 (USD Billion)
  • 5.11. Other
    • 5.11.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Drug Device Combination Products Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Disorder
    • 6.3.1. Global Drug Device Combination Products Market, by Cardiovascular Disorder, by Region, 2020-2034 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Global Drug Device Combination Products Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 6.5. Respiratory Problems
    • 6.5.1. Global Drug Device Combination Products Market, by Respiratory Problems, by Region, 2020-2034 (USD Billion)
  • 6.6. Cancer Treatment
    • 6.6.1. Global Drug Device Combination Products Market, by Cancer Treatment, by Region, 2020-2034 (USD Billion)
  • 6.7. Other
    • 6.7.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Drug Device Combination Products Market, by End-user

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Drug Device Combination Products Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Drug Device Combination Products Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Drug Device Combination Products Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Device Combination Products Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Drug Device Combination Products Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Drug Device Combination Products Market - North America
    • 8.3.1. North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.4. Drug Device Combination Products Market - U.S.
      • 8.3.4.1. U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.5. Drug Device Combination Products Market - Canada
      • 8.3.5.1. Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.4. Drug Device Combination Products Market - Europe
    • 8.4.1. Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.4. Drug Device Combination Products Market - UK
      • 8.4.4.1. UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.5. Drug Device Combination Products Market - France
      • 8.4.5.1. France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.6. Drug Device Combination Products Market - Germany
      • 8.4.6.1. Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.7. Drug Device Combination Products Market - Italy
      • 8.4.7.1. Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.8. Drug Device Combination Products Market - Spain
      • 8.4.8.1. Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.9. Drug Device Combination Products Market - Netherlands
      • 8.4.9.1. Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.10. Drug Device Combination Products Market - Russia
      • 8.4.10.1. Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.11. Drug Device Combination Products Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.5. Drug Device Combination Products Market - Asia Pacific
    • 8.5.1. Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.4. Drug Device Combination Products Market - China
      • 8.5.4.1. China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.5. Drug Device Combination Products Market - India
      • 8.5.5.1. India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.6. Drug Device Combination Products Market - Malaysia
      • 8.5.6.1. Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.7. Drug Device Combination Products Market - Japan
      • 8.5.7.1. Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.8. Drug Device Combination Products Market - Indonesia
      • 8.5.8.1. Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.9. Drug Device Combination Products Market - South Korea
      • 8.5.9.1. South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.10. Drug Device Combination Products Market - Australia
      • 8.5.10.1. Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.11. Drug Device Combination Products Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.6. Drug Device Combination Products Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.4. Drug Device Combination Products Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.5. Drug Device Combination Products Market - UAE
      • 8.6.5.1. UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.6. Drug Device Combination Products Market - Israel
      • 8.6.6.1. Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.7. Drug Device Combination Products Market - South Africa
      • 8.6.7.1. South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.8. Drug Device Combination Products Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.7. Drug Device Combination Products Market - Latin America
    • 8.7.1. Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.4. Drug Device Combination Products Market - Mexico
      • 8.7.4.1. Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.5. Drug Device Combination Products Market - Brazil
      • 8.7.5.1. Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.6. Drug Device Combination Products Market - Argentina
      • 8.7.6.1. Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.7. Drug Device Combination Products Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Medtronic
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sensely, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Stryker
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teleflex Incorporated
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Terumo Medical Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Viatris Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Hovione
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 4 North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 7 U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 10 Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 13 Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 16 UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 19 France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 22 Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 25 Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 28 Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 34 Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 43 China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 46 India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 52 Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 58 South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 61 Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 73 UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 76 Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 79 South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 85 Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 88 Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 91 Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 94 Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Drug Device Combination Products Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Drug Device Combination Products Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Drug Device Combination Products Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End-user
  • Figure 11. Global Drug Device Combination Products Market, by End-user, 2024 & 2034 (USD Billion)